Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
Open Access
- 1 January 2013
- journal article
- review article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 19 (1), 1-16
- https://doi.org/10.3350/cmh.2013.19.1.1
Abstract
The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses no risk of nephrotoxicity and requires no ionizing radiation. The unique features of contrast enhanced US (CEUS) are not only noninvasiveness but also real-time assessing of liver perfusion throughout the vascular phases. The later feature has led to dramatic improvement in the diagnostic accuracy of US for detection and characterization of FLLs as well as the guidance to therapeutic procedures and evaluation of response to treatment. This article describes the current consensus and guidelines for the use of UCAs for the FLLs that are commonly encountered in US. After a brief description of the bases of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs and other clinical applications are described and discussed on the basis of our experience and the literature dataKeywords
This publication has 95 references indexed in Scilit:
- Early Response to Anti-Tumoral Treatment in Hepatocellular Carcinoma - Can Quantitative Contrast-Enhanced Ultrasound Predict Outcome?Ultraschall in der Medizin - European Journal of Ultrasound, 2012
- Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJournal of Hepatology, 2012
- Frequency of Tumor Entities among Liver Tumors of Unclear Etiology Initially Detected by Sonography in the Noncirrhotic or Cirrhotic Livers of 1349 PatientsUltraschall in der Medizin - European Journal of Ultrasound, 2011
- Value of contrast‐enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinomaJournal of Clinical Ultrasound, 2011
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary ResultsRadiology, 2011
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Peripheral Mass–Forming Cholangiocarcinoma in Cirrhotic LiverAmerican Journal of Roentgenology, 2007
- New perspectives for the use of contrast-enhanced liver ultrasound in clinical practiceDigestive and Liver Disease, 2007
- The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigationsJapanese Journal of Clinical Oncology, 2006